openPR Logo
Press release

Accelerated Growth in AI-Based Clinical Trial Solutions Market Driven by Rising Adoption of AI Technology: A Key Factor Shaping the Future of the AI-Based Clinical Trial Solution Providers Market in 2025

03-07-2025 02:14 PM CET | Health & Medicine

Press release from: The Business Research Company

AI Based Clinical Trial Solution Providers Market

AI Based Clinical Trial Solution Providers Market

Which drivers are expected to have the greatest impact on the over the ai-based clinical trial solution providers market's growth?
The AI-based clinical trial solution provider market is poised for growth due to the rising adoption of AI technology. AI, or artificial intelligence, pertains to the creation of software or computer systems capable of performing tasks that usually require human intelligence. Clinical trial solution providers are utilizing AI technology more extensively to introduce accuracy, efficiency, and innovation to different clinical trial lifecycle stages. This is significantly contributing to enhanced patient results and medical research advancements. As referenced by The International Business Machines Corporation (IBM), a technology corporation based in the United States, the global AI adoption rate has seen a substantial rise of 35% in May 2022, an increase of four points from the previous year. Moreover, 2022 is expected to see a 13% increase in firms using AI compared to 2021, while nearly 35% of organizations have incorporated AI into their operations. 42% of firms are contemplating AI adoption, and 66% of the companies are already employing or planning to employ AI to reach their sustainability objectives. Consequently, the rising adoption of AI technology fuels the growth of the AI-based clinical trial solution provider market.

Get Your AI-Based Clinical Trial Solution Providers Market Report Here:
https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

What is the future CAGR of the ai-based clinical trial solution providers market, and how will it impact industry expansion?
The market size for AI-based clinical trial solution providers has experienced substantial growth over recent years. The market is projected to enlarge from $2.47 billion in 2024 to $3.04 billion in 2025, showing a compound annual growth rate (CAGR) of 23.1%. Reasons for this growth over the historical period include the rising intricacy of clinical trials, an increase in the volume of clinical trial data, challenges around regulatory compliance, the need for drug discovery and development, and trends in personalized medicine.

In the forthcoming years, a significant upsurge is anticipated in the market size of AI-based clinical trial solutions providers, with projections indicating a growth to $6.96 billion by 2029 at a 23.0% compound annual growth rate (CAGR). Factors contributing to this growth in the forecast period include its integration with Real-World Evidence (REW), advancements in Natural Language Processing (NPL), adoption of decentralized clinical trials, expansion into new therapeutic areas, and improved predictive analytics. The forecast period will also see trends like collaborations with biotech and pharma firms, patient-focused approaches, the use of predictive analytics for trial design, incorporation of real-world evidence, and the application of blockchain for data security.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13575&type=smp

What are the most significant trends transforming the ai-based clinical trial solution providers market today?
Leading businesses in the AI-centric clinical trial solutions sector are making ground-breaking technological advancements, such as Saama's AI-powered data platform, to expedite clinical development and establish a strong market position. An AI-powered data platform is a software solution that uses artificial intelligence (AI) and machine learning (ML) to automate and improve several data management and analytical processes. For example, in June 2023, Saama Technologies Inc., stationed in the US, unveiled an AI-powered data platform known as Saama. This AI-powered platform eases clinical trial procedures by unifying and normalizing data, providing real-time findings on trial operations, financials, and patient data. The platform employs AI and sophisticated analytics to automate tasks, boost productivity, and offer deep insights into patient actions. Through SaaS solutions like data hubs, operational insights, patient insights, S2S, and SDQ, Saama enables AI-centric clinical trial solution providers to maximize efficiency, precision, and efficacy. Furthermore, it seeks to eradicate manual, resource-demanding activities, thereby making clinical trials more efficient and effective.

Which key market segments comprise the ai-based clinical trial solution providers market and drive its revenue growth?
The AI-based clinical trial solution providers market covered in this report is segmented -

1) By Clinical Trial Phase: Phase-I, Phase-Ii, Phase-Iii
2) By Therapeutic Application: Oncology, Cardiovascular Diseases, Neurological Diseases Or Conditions Metabolic Diseases, Infectious Diseases, Other Therapeutic Applications
3) By End-User: Pharmaceutical Companies, Academia, Other End-Users

Subsegments:
1) By Phase-I: Safety And Dosage Studies, Early Pharmacokinetics Studies
2) By Phase-Ii: Efficacy Studies, Dose-Response Studies
3) By Phase-Iii: Confirmatory Studies, Comparative Effectiveness Research

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13575

What regions are at the forefront of ai-based clinical trial solution providers market expansion?
North America was the largest region in the AI-based clinical trial solution providers market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai-based clinical trial solution providers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the ai-based clinical trial solution providers market?
Major companies operating in the AI-based clinical trial solution providers market report are International Business Machines Corporation, AstraZeneca, Takeda Pharmaceutical Company Limited, IQVIA Holdings Inc., BenevolentAI SA, Charles River Laboratories, Flatiron Health, Saama Technologies Inc., CytoReason, Median Technologies SAS, Concentro Health AI., AiCure, LLC, DEEP LENS AI Inc., GNS Healthcare, Inc., Ardigen, Koneksa Health Inc., Unlearn.AI Inc., PathAI Inc., Deep 6 AI Inc., Intelligencia Inc., Exscientia, Prometheus Biosciences, Inc., Renalytix AI PLC, BioAge Labs Inc., Mendel Health Inc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13575&type=smp

What Is Covered In The AI-Based Clinical Trial Solution Providers Global Market Report?

• Market Size Forecast: Examine the ai-based clinical trial solution providers market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the ai-based clinical trial solution providers market for a structured understanding.
• Key Players Overview: Analyze major players in the ai-based clinical trial solution providers market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ai-based clinical trial solution providers market.
• Segment Contributions: Evaluate how different segments drive overall growth in the ai-based clinical trial solution providers market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ai-based clinical trial solution providers market.
• Industry Challenges: Identify potential risks and obstacles affecting the ai-based clinical trial solution providers market.
• Competitive Landscape: Review strategic developments in the ai-based clinical trial solution providers market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Accelerated Growth in AI-Based Clinical Trial Solutions Market Driven by Rising Adoption of AI Technology: A Key Factor Shaping the Future of the AI-Based Clinical Trial Solution Providers Market in 2025 here

News-ID: 3904667 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical